Nasdaq:US$32.32 (+0.02) | HKEX:HK$50.35 (-0.45) | AIM:£4.72 (+0.04)
活動,通告及表格
上一篇文章   |   下一篇文章
事件 | 2017-03-30

R&D Briefing for Investors 2017

Introduction
The Future of Targeted Cancer Therapy In Lung Cancer
Post-POC Portfolio
Pre-POC Portfolio
Research Strategy
Transforming into a Fully Integrated Global Biopharma

Wed. Mar 29, 9:30am – South Place Hotel, London, UK
» Click here to watch a replay of the event, including a keynote from Susan Galbraith, SVP of Oncology iMed, AstraZeneca

 

Thu. Mar 30, 8:30am – W Hotel, New York, NY
» Click here to watch a webcast of the event

 

» See press release for a description of the event